Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease (Q38265002)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

1 reference

Europe PubMed Central

Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease (English)

1 reference

Europe PubMed Central

1 September 2017

0 references

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

Daniel Medeiros Moreira

1

1 reference

Europe PubMed Central

1 September 2017

Roberto Leo da Silva

2

1 reference

Europe PubMed Central

1 September 2017

Jefferson Luís Vieira

3

1 reference

Europe PubMed Central

1 September 2017

Tammuz Fattah

4

1 reference

Europe PubMed Central

1 September 2017

Maria Emilia Lueneberg

5

1 reference

Europe PubMed Central

1 September 2017

Carlos Antonio Mascia Gottschall

6

1 reference

Europe PubMed Central

1 September 2017

publication date

1 February 2015

1 reference

Europe PubMed Central

1 September 2017

American journal of cardiovascular drugs

1 reference

Europe PubMed Central

1 September 2017

15

1 reference

Europe PubMed Central

1 September 2017

1

1 reference

Europe PubMed Central

1 September 2017

1-11

1 reference

Europe PubMed Central

1 September 2017

https://scigraph.springernature.com/pub.10.1007/s40256-014-0094-z

0 references

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, a

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Innate and adaptive immunity in the pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Interleukin-6 and the acute phase response

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Identification of an inducible endothelial-leukocyte adhesion molecule

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The response-to-retention hypothesis of early atherogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The oxidation hypothesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Low density lipoprotein oxidation and its pathobiological significance

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Inflammation and coagulation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Heat shock protein 60 and immune inflammatory responses in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

C5a-induced expression of P-selectin in endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Lymphocytes are important in early atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Adaptive immunity in atherogenesis: new insights and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Peripheral B cell subsets

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

B cell depletion reduces the development of atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

BAFF receptor deficiency reduces the development of atherosclerosis in mice--brief report.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Pro-inflammatory genetic markers of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

A variant in the ABO gene explains the variation in soluble E-selectin levels-results from dense genotyping in two independent populations

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

A genome-wide association scan on the levels of markers of inflammation in Sardinians reveals associations that underpin its complex regulation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Relationship of admission neutrophil count to microvascular injury, left ventricular dilation, and long-term outcome in patients treated with primary angioplasty for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Evidence for an active inflammatory process in the hibernating human myocardium

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Colchicine update: 2008.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Low-dose colchicine for secondary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Treatment with methotrexate inhibits atherogenesis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Anti-atherogenic effects of methotrexate carried by a lipid nanoemulsion that binds to LDL receptors in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: a randomized double-blind, placebo-controlled trial (METIS trial).

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Rationale and design of the TETHYS trial: the effects of methotrexate therapy on myocardial infarction with ST-segment elevation.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Complement regulation in human atherosclerotic coronary lesions

1 reference

https://api.crossref.org/works/10.1007%2FS40256-014-0094-Z

21 January 2018

Identifiers

10.1007/S40256-014-0094-Z

1 reference

Europe PubMed Central

1 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38265002&oldid=1751452751"